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Implication for health policy/practice/research/medical education:
In a study on 29 selected IgA nephropathy patients , we found that C4d immunostaining has a significant positive correlation 
with serum creatinine, level of  proteinuria, proportion of  globally sclerotic glomeruli and quantity of  tubulointerstitial fibrosis 
in patients with IgAN. Staining for C4d could be incorporated into the routine analysis of  kidney biopsies in patients with IgAN, 
given its prognostic implication. Our findings, however, require further investigation with larger samples.
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Background: IgA nephropathy (IgAN) is the most prevalent primary chronic glomerulopathy 
worldwide. Thus, it is of  vital importance to search for factors aggravating the disease 
progress, monitor disease activity and predict disease-specific therapy. C4d is a well-known 
biomarker of  the complement cascade with a potential to meet the above needs.
Objectives: The aim of  our study was, therefore, to determine whether C4d staining at the 
time of  kidney biopsy had any correlation with the demographic, clinical and biochemical 
variables in IgAN. 
Patients and Methods: The definition of  IgAN requires the presence of  diffuse and global 
IgA deposits which were graded ≥2+ and weak C1q deposition. C4d immunohistochemical 
staining was conducted retrospectively on 29 renal biopsies of  patients with IgAN, which 
were selected randomly from all biopsies. C4d immunohistochemical staining was performed 
on 3-μm deparaffinized and rehydrated sections of  formaldehyde-fixed, paraffin-embedded 
renal tissues.
Results: Of  29 selected patients, 68% were male. In this study, 54.2±25 percent of  glomeruli in 
all biopsies were positive for C4d. The mean and standard deviation (SD) of  serum creatinine 
and the magnitude of  proteinuria were 1.72±1.2 mg/dl and 1582±1214 mg/day, respectively. 
In this study, we observed statistically significant correlations of  percent C4d positivity with 
the serum creatinine (r=0.61, p=0.0005), magnitude of  proteinuria (r=0.72, p=0.0001), 
the proportion of  globally sclerotic glomeruli (r=0.43, p=0.02) and the proportion of 
tubulointerstitial fibrosis (r=0.54, p=0.0023). 
Conclusions: The results from our investigation on C4d positivity in biopsy-proven cases of 
IgAN are in accord with some of  the previous studies. These findings, however, require 
further validation in larger samples.
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1. Background
IgA nephropathy (IgAN) is the most common 
glomerulopathy in the world (1,2). The diagnosis of 
IgAN is based on the preponderance of  IgA deposits, 
with C3 in the mesangial area of  the glomeruli (3-
6). Low intensity of  IgG or IgM deposits may also 
be found. C1q deposition is typically absent and its 
absence is a diagnostic clue for the immunohistological 
diagnosis of  the disease. In some patients, the 
mesangial deposits may extend to capillary walls 
too (2-4). Since IgAN is the most prevalent primary 
chronic glomerulopathy and it leads to end-stage 
renal disease (ESRD) in up to 30-40% of  cases, it is 
of  vital importance to search for factors influencing 
the disease progress, monitoring the disease activity 
and predicting disease-specific therapy (6). The recent 
Oxford Classification of  IgAN recognized mesangial 
hypercellularity, endocapillary proliferation, segmental 
glomerulosclerosis, and tubular atrophy/interstitial 
fibrosis, as independent predictors of  outcome (7-
10). However, other morphologic variables and 
immunostaining data may have significant importance 
and require further investigation (7-12).
While IgAN is supposed to be associated with 
immunoglobulin deposition in the kidney, the exact 
pathogenesis still remains undetermined (13,14). 
Additionally, immune complex-mediated complement 
activation via the classical pathway plays a key role in 
the pathogenesis of  various glomerulonephritides 
(14-19). In summary, the classical pathway is 
commenced by the binding of  the complement 
C1 complex to the antigen-antibody complex or 
C-reactive protein, which is followed by the cleavage 
of  the complement component C4 into C4a and C4b, 
and then C4b is cleaved into C4c and C4d (18-20). 
Recently much attention has been directed towards 
the detection and significance of  C4d mesangial 
deposits and its association with various clinical and 
morphologic lesions in glomerulopathies; however, 
few studies have been published on this subject 
(18-21). C4d is also generated by activation of  the 
lectin pathway. It has been found that patients with 
IgAN can be divided into two groups on the basis of 
the pattern of  complement activation. Activation of 
the lectin pathway of  complement is associated with 
more severe kidney disease. Glomerular deposition of 
C4d is an indicator of  activation of  the lectin pathway 
of  complement (18-21). Hence, C4d is a well-known 
biomarker of  the complement cascade. Moreover, 
C4d staining is an inexpensive and easy method for 
the analysis of  kidney biopsies (18-23).
Though C4d itself  has no biological function, it has 
established role for its indication of  complement 
activation through the classical, alternative or lectin 
pathway (18-21). In one study Espinosa et al. proposed 
that C4d is a valuable tool for the differential 
diagnosis of  membranous nephropathy (24). Thus, 
it is reasonable to extend the study of  C4d to other 
immunologic diseases, including IgAN, to find the 
role of  C4d and its clinical implication. 
2. Objectives
The aim of  our study was therefore to determine 
whether C4d staining at the time of  the kidney biopsy 
had any correlation with the clinical and biochemical 
variables in IgAN. 
3. Patients and Methods
3.1. Definition of  IgAN
The pathologic diagnosis of  IgAN requires 
demonstration of  IgA-dominant or codominant 
mesangial or mesangial-capillary immune deposits 
through immunofluorescence (IF) microscopy with 
subdominant, or weak deposits for C1q. The immune 
deposits were semiquantified from 0 to 3+ positive 
intensity of  brightness (23,24). The definition of 
IgAN requires the presence of  diffuse and global 
IgA deposits which were graded ≥2+ and weak C1q 
deposition (23-25). All kidney biopsies, conducted 
at various medical centers, were sent to a reference 
laboratory. None of  the patients was treated before 
the biopsy. Biopsies with less than eight glomeruli 
were excluded from the investigation. None of  the 
patients was diagnosed as primary IgAN, having a 
history of  collagen vascular diseases, diabetes or liver 
cirrhosis based on a questionnaire filled at the time of 
biopsy admission, laboratory data in patients’ records 
and a brief  history provided by referee physicians at 
the time of  biopsy admission.
3.2. Histologic data
All renal biopsies were prepared for light and direct 
IF microscopy. Tissue was fixed in 10% formalin 
for histologic sectioning. Each kidney biopsy was 
prepared by cutting paraffin blocks into 3-μm 
sections and staining for periodic acid Schiff  (PAS), 
hematoxylin and eosin (H&E), Jones silver stain and 
trichrome (23-25). Each slide contained 2-3 sections. 
The specimen for IF was snap-frozen in liquid 
nitrogen. Sections (5µ in thickness) were stained for IF 
study with IgG, IgM, IgA, C3, and C1q. IF slides were 
reported on a scale of  0-3+ bright intensity and by a 
nephropathologist (23-25). IF study was performed 
before reviewing the slides for light microscopy 
unaware of  patients’ data. 
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3.3. Definitions of  morphologic variables
Total number of  glomeruli and the number of 
glomeruli with global sclerosis were recorded for each 
biopsy. The presence of  (I) mesangial hypercellularity 
(M), (II) endocapillary proliferation (E), (III) segmental 
glomerulosclerosis (S) and (IV) the proportion of 
tubular atrophy and interstitial fibrosis (IF/TA) was 
assessed as published for Oxford classification of 
IgAN (23-25).
3.4. C4d staining and histological study
C4d immunohistochemical staining was conducted 
retrospectively on 29 of  renal biopsies of  patients 
with IgAN, who were selected by systematic random 
sampling from all biopsies. C4d immunohistochemical 
staining was performed on 3-μm deparaffinized and 
rehydrated sections of  formaldehyde-fixed, parafin-
embedded renal tissues, using rabbit polyclonal 
anti-human C4d (Biomedica, Vienna, Austria) as the 
primary antibody, diluted 1:50 in antibody diluent 
(Dako, Denmark). In order to break the cross-linking 
of  the proteins which were caused during tissue 
processing and to unmask the target protein epitopes, 
heat-induced antigen retrieval (HIER) was performed 
in advance using microwave (10 min at high power, 
10 mM citrate buffer, pH 6.0). After cooling down for 
15 min at room temperature, endogenous peroxidase 
was blocked with 3% H2O2 for 5 min, followed by 
washing the sections in TBS. Anti-C4d antibody was 
applied for 30 min at room temperature, followed by 
washing in TBS. The detection system used was Dako 
EnVision (Dako, Glostrup, Denmark) applied for 
30 min at room temperature, followed by washing in 
TBS. The signal was detected with DAB chromogen 
(Dako, Glostrup, Denmark) for 15 min, resulting 
in a brown color. Following the washing step in 
tap water for a few min, slides were counterstained 
with hematoxylin (Dako, Glostrup, Denmark) for 2 
min. After dehydrating, the slides were cover-slipped 
using mounting medium. C4d immunohistochemical 
staining was assessed by the percent of  C4d positivity 
in the glomeruli in each biopsy, through evaluation 
of  all glomeruli in every fragment. More than trace 
positivity of  C4d in the glomeruli was considered as 
positive. 
3.5. Clinical studies and laboratory data
In this retrospective histological study, the medical 
records of  patients were reviewed to obtain various 
demographic, clinical and laboratory information at 
the time of  biopsy and for follow-up activities. Data 
gathered at the time of  biopsy included race, gender, 
age, serum creatinine (Cr) and proteinuria (based on a 
24-h urine collection).
3.6. Ethical issues
1) The research followed the tenets of  the Declaration 
of  Helsinki; 2) informed consent was obtained; and 3) 
the research was approved by the institutional review 
board.
3.7. Statistical analysis
The mean values and standard deviations (mean 
±SD) were calculated. To obtain a correlation matrix 
for quantitative variables in the dataset was used the 
Spearman’s correlation. Data were analyzed by Stata 
software version 12 (Stata Corporation, College 
Station, Texas). P values of  less than 0.05 was assumed 
to be significant (p<0.05).
4. Results
Of  29 selected patients, 68% were male and 32% 
female. The mean±SD, minimum and maximum of 
age of  patients were 35.03 (±11.7), 17 and 56 years. 
The mean ±SD of  serum creatinine and quantity of 
proteinuria were 1.72±1.2 mg/dl and 1582±1214 
mg/day, respectively. In this study, 54.2±25% of 
all glomeruli were positive for C4d. In this study, a 
significant positive correlation of  C4d with serum 
creatinine (r=0.61, p=0.0005; Figure 1), quantity of 
proteinuria (r=0.72, p=0.0001; Figure 2), proportion 
of  globally sclerotic glomeruli (r=0.43, p=0.02) 
and quantity of  tubulointerstitial fibrosis (r=0.54, 
p=0.0023) was seen. The 95% confidence intervals 
of  these are shown in Table 1. Representative 
photomicrographs of  C4d positivity by IHC are 
shown in Figure 3. 
5. Discussion
Positive C4d staining in the glomeruli may be 
correlated with functional damage related to 
glomerular filtration and poor kidney outcome 
(18-22). It has been detected that patients with IgAN 
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Figure1: correlation of C4d with serum creatinine
Figure 1. Correlation of  C4d with serum creatinine 
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can be divided into two groups on the basis of  the 
mode of  complement activation. Activation of  the 
lectin pathway of  complement is correlated with more 
severe kidney disease (18-22). Glomerular deposition 
of  C4d is an indicator of  activation of  the lectin 
pathway of  complement (18-22). In a retrospective 
investigation by Espinosa et al., comprising of 
patients with IgAN who underwent kidney biopsy, 
the baseline age, gender, presence of  macroscopic 
hematuria, hypertension, serum creatinine and 
glomerular filtration rate, urine protein, mesangial 
C4d staining, glomerulosclerosis, interstitial fibrosis 
and extracapillary proliferation were investigated (24). 
They found that overall 32.2% were C4d positive and 
67.8% C4d negative. They detected that C4d-positive 
staining was univariately associated with evolution to 
end-stage kidney failure. Moreover, kidney survival at 
10-years was 43.9% in C4d-positive patients versus 
90.9% in C4d-negative patients (24). They interpreted 
that, negative mesangial C4d-staining in glomeruli in 
IgAN helps to define patients with a good long-term 
prognostic outcome (24). In a retrospective study 
including 23 IgAN patients, C4d staining and medical 
records including gender, age, and urine albumin were 
reviewed by Maeng and colleagues (25). Thirteen 
patients (56.5%) were positive for C4d staining in 
the glomerulus (25). They found that glomerular 
C4d deposition was associated with albuminuria 
(25). These findings are in accord with the results 
of  our study too. More recently, in a retrospective 
investigation consisting of  283 patients with IgAN, 
by Espinosa et al., C4d was investigated (26). The 
study showed that 109 patients and 174 patients 
were classified as C4d-positive and C4d-negative, 
respectively. Kidney survival at 20-years was 28% in 
C4d-positive patients versus 85% in C4d-negative 
patients. They concluded that, C4d-positive staining 
is an independent risk factor for the development of 
end-stage kidney failure in IgAN patients (26). 
6. Conclusions
In conclusion, our investigation shows that C4d 
immunostaining has a significant positive correlation 
with serum creatinine, level of  proteinuria, proportion 
of  globally sclerotic glomeruli and quantity of 
tubulointerstitial fibrosis in patients with IgAN. 
Staining for C4d could be incorporated into the 
routine analysis of  kidney biopsies in patients with 
IgAN, given its prognostic implication. Our findings, 
however, require further investigation with larger 
samples.
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Figure 2. Correlation of  C4d with quantity of  proteinuria
Table 1. Correlation (r) and 95% confidence intervals (CI) 
between C4d and serun creatinine, level of  proteinuria/day, 
proportion of  globally sclerotic glomeruli, and quantity of 
tubulointerstitial fibrosis.
Variable C4dr CI 95% P
Creatinine (mg/dl) 0.61 0.31-0.79 0.0005*
Proteinuria/day 0.72 0.48-0.86 0.0001*
Proportion of  globally 
sclerotic glomeruli
(number)
0.43 0.35-0.68 0.02*
Tubulointerstitial fibrosis
(%)
0.54 0.22-0.75 0.0023*
*P value less than 0.05 and was significant.
Figure 3. C4d immunohistochemical staining in IgA ne-
phropathy. A) Low-power view showing glomerular pos-
itivity of  C4d. The surrounding parenchyma is negative. 
(C4d, ×100). B) High-power view showing predominantly 
mesangial positivity of  C4d. (C4d, ×400). C) Medium-pow-
er view showing mesangial and membranous positivity of 
C4d. (C4d, ×200). D) High-power view showing both me-
sangial and capillary wall positivity of  C4d. (C4d, ×400).
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